Quoin Pharmaceuticals
QNRX
7 hedge funds and large institutions have $23.4K invested in Quoin Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
0.38% more ownership
Funds ownership: 0.06% → 0.43% (+0.38%)
22% less funds holding
Funds holding: 9 → 7 (-2)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
74% less capital invested
Capital invested by funds: $90.2K → $23.4K (-$66.8K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GI
GAMMA Investing
Foster City,
California
|
+$1.84K |
| 2 |
Morgan Stanley
New York
|
+$1.48K |
| 3 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$376 |
| 4 |
HNB
Huntington National Bank
Columbus,
Ohio
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$47K |
| 2 |
AWM
Apollon Wealth Management
Mount Pleasant,
South Carolina
|
-$17.9K |
| 3 |
Lido Advisors
Los Angeles,
California
|
-$5.26K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.57K |
| 5 |
JP Morgan Chase
New York
|
-$33 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
RhumbLine Advisers
Boston,
Massachusetts
| $11.4K | +$376 | +49 | +4% |
|
2
Raymond James Financial
St Petersburg,
Florida
| $6.62K | -$8 | -1 | -0.1% |
|
|
GI
3
GAMMA Investing
Foster City,
California
| $2.21K | +$1.84K | +240 | New |
|
|
4
Morgan Stanley
New York
| $1.9K | +$1.48K | +193 | +1,485% |
|
|
5
UBS Group
Zurich,
Switzerland
| $1.2K | -$47K | -6,136 | -98% |
|
|
SS
6
SBI Securities
Tokyo,
Japan
| $18 | -$8 | -1 | -33% |
|
|
HNB
7
Huntington National Bank
Columbus,
Ohio
| $6 | +$8 | +1 | New |
|
|
AWM
8
Apollon Wealth Management
Mount Pleasant,
South Carolina
| – | -$17.9K | -2,286 | Closed |
|
|
9
Lido Advisors
Los Angeles,
California
| – | -$5.26K | -672 | Closed |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$2.57K | -320 | Closed |
|
|
11
JP Morgan Chase
New York
| – | -$33 | -4 | Closed |
|
|
RBI
12
Raiffeisen Bank International
Vienna,
Austria
| – | -$4 | – | – |
|
QNRX Hedge Fund Activity: Q2 2025 in Review
7 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q2 2025, worth a combined $23.4K — down 74% from $90.2K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of QNRX and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was GAMMA Investing, opening a new position worth an estimated $1.84K. The largest seller was UBS Group, cutting an estimated $47K.
- 7 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q2 2025, down from 9 in Q1 2025.
- Funds reported $23.4K of Quoin Pharmaceuticals stock for Q2 2025, down 74% quarter-over-quarter.
- 2 funds opened new Quoin Pharmaceuticals positions in Q2 2025 and 4 closed out, a net change of -2 holders.
- The largest Quoin Pharmaceuticals buyer in Q2 2025 was GAMMA Investing, an estimated $1.84K added.
- The largest Quoin Pharmaceuticals seller in Q2 2025 was UBS Group, an estimated $47K sold.
Based on aggregated 13F filings for Q2 2025.